Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.
PMID 19706770 · PMC2745517 · Cancer research · 2009 · 8 claims · 8 setups
Genome-wide DNA copy number analysis of 161 primary breast tumors identified six novel focally amplified genes: POLD3, IRAK4, IRX2, TBL1XR1, ASPH, and BRD4
-
Full-text index only
Personalized copy number and segmental duplication maps using next-generation sequencing.
PMID 19718026 · PMC2875196 · Nature genetics · 2009 · 5 claims · 5 setups
mrFAST maps short reads to all possible locations in the reference genome, enabling read-depth-based prediction of absolute copy number in both unique and duplicated sequence, including discrimination between highly identical gene paralogs.
-
Full-text index only
Protocol for quantifying interaction patterns among genomic alterations in cancer.
PMID 41686643 · PMC12915222 · STAR protocols · 2026 · 6 claims · 5 setups
Background-aware permutation strategies that constrain permutation per gene and per sample enable robust, scalable inference of condition-specific (context-aware) genetic interactions across cancer cohorts
-
Full-text index only
Segmental copy number amplifications are more stable than aneuploidies in the absence of selection.
PMID 41968576 · PMC13107562 · Molecular biology and evolution · 2026 · 8 claims · 6 setups
Segmental amplifications are stable in the absence of selection, whereas aneuploidies are rapidly lost and revert to single-copy genotype
-
Full-text index only
Molecular profiling of breast cancer in native American women reveals distinct genomic and transcriptomic features.
PMID 41844957 · PMC13144316 · NPJ precision oncology · 2026 · 8 claims · 6 setups
This is the first multi-omics (mutation, CNV, RNA-seq) characterization of breast tumors from Native American women, providing a resource for future studies
-
Full-text index only
Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma.
PMID 41916296 · PMC13130669 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
Immune and stromal heterogeneity, rather than genetic variation, are primary drivers of gene expression ITH in iCCA
-
Full-text index only
Distinct molecular and tumor microenvironment characteristics of mucinous adenocarcinoma in colorectal cancer.
PMID 42100746 · PMC13145884 · iScience · 2026 · 8 claims · 8 setups
MAC is associated with significantly worse overall survival than CAC, but only within the MSS subtype
-
Full-text index only
Single-Cell RNA Analysis of Murine Osteosarcoma Uncovers Skp2 Function in Metastasis, Genomic Instability, and Immune Activation and Reveals Additional Target Pathways.
PMID 41877584 · PMC13103941 · Cancer research communications · 2026 · 8 claims · 6 setups
Skp2 KO improves survival, drives apoptosis, and induces antitumor immunity in Rb1/Trp53-deficient murine osteosarcoma
-
Has reproduction · 69
Meta-analysis of six dairy cattle breeds reveals biologically relevant candidate genes for mastitis resistance.
PMID 39009986 · PMC11247842 · Genetics, selection, evolution : GSE · 2024 · 5 claims · 8 setups
Meta-analysis of GWAS across six dairy cattle breeds identifies 58 lead markers associated with clinical mastitis and somatic cell score
-
Has reproduction · 30
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer.
PMID 35311085 · PMC8930202 · Frontiers in oncology · 2022 · 8 claims · 8 setups
BCG therapy has bidirectional effects on tumor evolution and immune checkpoint landscape, with a significant reduction in neoantigen burden percentage in relapsed tumors
-
Full-text index only
Repurposing public sarcoma multi-omics for neoantigen discovery.
PMID 42012689 · PMC13100081 · Cancer immunology, immunotherapy : CII · 2026 · 8 claims · 7 setups
Reanalysis of legacy CKS multi-omic data shows that standard genome-wide metrics frequently underestimate the true immunogenic potential of these tumors.